Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Controlled release carbidopa/levodopa (
CSR
-1) was compared to standard carbidopa/levodopa in a double-blind, crossover study of 20
Parkinson's disease
patients. The most consistent finding in a variety of clinical measurements was the superiority of standard carbidopa/levodopa to
CSR
-1. Increased dosages of
CSR
-1 resulted in reduced Parkinson symptoms, suggesting that a more potent controlled-release formulation might prove to be more efficacious than
CSR
-1.
...
PMID:Controlled-release carbidopa/levodopa in the treatment of Parkinsonism. 637 61
